Charlie Petty
Oprichter bij Adjuvant Capital LP
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Glenn Rockman | M | 43 |
VitriVax, Inc.
VitriVax, Inc. BiotechnologyHealth Technology VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider.
Codagenix, Inc.
Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 6 jaar |
Lilly deSouza Burr | F | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 5 jaar |
Matthew Lanchantin | M | - |
Nucleate Bio, Inc.
| 5 jaar |
Labeeb Abboud | M | - |
Global Health Investment Corp.
| - |
Max Henderson | M | - |
Effective Giving
| 5 jaar |
Sofia Guerra | F | - |
Nucleate Bio, Inc.
| 5 jaar |
Kim Kamdar | M | 56 |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Michael Chang | M | - |
Global Health Investment Corp.
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 6 jaar |
Kabeer Aziz | M | 34 |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 6 jaar |
Baeksik Bae | M | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | 2 jaar |
Charles Petty | M | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | 2 jaar |
Lisa Shelton | F | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | 2 jaar |
Sophie Allauzen | F | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
David Washer | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 3 jaar |
Gerard Cunningham | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 4 jaar |
Mario Barro | M | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | 2 jaar |
Christian Mandl | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 5 jaar |
Jim Robinson | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Peter Patriarca | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Michael Hodges | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Jae Uk Jeong | M | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | 2 jaar |
Steven Reed | M | 73 |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | - |
George Simeone | M | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | - |
Jill Howe | F | 48 |
Codagenix, Inc.
Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | 3 jaar |
Richard T. Crowder | M | 84 |
Virginia Polytechnic Institute & State University
| 16 jaar |
Jenny Yip | F | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 5 jaar |
Justin Olshavsky | M | - |
Nucleate Bio, Inc.
| 2 jaar |
Matthew Raider | M | - |
VitriVax, Inc.
VitriVax, Inc. BiotechnologyHealth Technology VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider. | - |
Dena Marrinucci | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 3 jaar |
Lori Rudolph-Owen | M | - |
Codagenix, Inc.
Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | 3 jaar |
Mark Sullivan | M | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | 4 jaar |
Evelyn Yanatos | F | - |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
David Miller | M | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | 1 jaar |
Curt LaBelle | M | 53 |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | - |
Paul Grint | M | 66 |
Codagenix, Inc.
Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | 2 jaar |
John Maraganore | M | 60 |
Nucleate Bio, Inc.
| - |
Lisa Runco | M | - |
Codagenix, Inc.
Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Colin Smith | M | - |
Virginia Polytechnic Institute & State University
| 6 jaar |
Dave Marone | M | - |
Virginia Polytechnic Institute & State University
| 7 jaar |
Benjamin Owens | M | - |
Virginia Polytechnic Institute & State University
| 7 jaar |
Kyle Stults | M | - |
VitriVax, Inc.
VitriVax, Inc. BiotechnologyHealth Technology VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider. | 1 jaar |
Christina Williams | F | - |
Virginia Polytechnic Institute & State University
| 5 jaar |
Brian Dang | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Timothy Duffy | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Katie Launspach | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Basheer Zada | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Thorne Whiteside Michaels | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Logan Miller | M | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Sarah Halvonik | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Andrew Newton | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
jason Ioannides | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Alex Crawford | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Julian van Giessen | M | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Mehul Chavada | M | - |
Virginia Polytechnic Institute & State University
| 1 jaar |
Constantine Saab | M | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Tom Howard | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Scott Reina | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Yi Tang | M | - |
Virginia Polytechnic Institute & State University
| 2 jaar |
Diaz Faisal Hendropriyono | M | 46 |
Virginia Polytechnic Institute & State University
| 1 jaar |
Conor Battle | M | - |
Virginia Polytechnic Institute & State University
| 5 jaar |
Brandon Joseph Cawley | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Leo (Naiwen) Cui | M | - |
Nucleate Bio, Inc.
| 2 jaar |
Sungkwon Kang | M | - |
Virginia Polytechnic Institute & State University
| 5 jaar |
Abhishek Gupta | M | - |
Nucleate Bio, Inc.
| 1 jaar |
Jason Weiskopf | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Natalie Okeson | F | - |
Virginia Polytechnic Institute & State University
| 2 jaar |
Brendon Dashiell | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Julian van Giessen | M | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Alex Rooney | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Sibi Gnanasundaram | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Ke Jin | M | 46 |
Virginia Polytechnic Institute & State University
| 1 jaar |
Greg Cole | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Christina Smith | F | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Erik Gatenholm | M | 35 |
Virginia Polytechnic Institute & State University
| 4 jaar |
Michael Rihani | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Richard Phillips | M | 69 |
Virginia Polytechnic Institute & State University
| 2 jaar |
Patrick Strollo | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Jeffrey R. Mettam | M | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Patrick Gartlan | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Tyler Hart | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Mike Kemp | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Tatiana Mishin | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Nandan A. Shah | M | - |
Virginia Polytechnic Institute & State University
| 5 jaar |
Abby Just | F | - |
Virginia Polytechnic Institute & State University
| 2 jaar |
Kelly O. Loveless | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Cam Martin | M | - |
Virginia Polytechnic Institute & State University
| 1 jaar |
Cooper J. Morgenthau | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Brittany Seaton | F | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Alia Elizabeth Wagenhoffer | F | - |
Virginia Polytechnic Institute & State University
| 3 jaar |
Chris Dorsey | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Michael J. Sherman | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Dana N. Hummel | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Dan Donahoe | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Eric Josef Schaefer | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Melissa L. Leonard | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Chris Kiessling | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
David W. Lazarek | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Deanna McGreevy | F | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Brandon M. Brooks | M | - |
Virginia Polytechnic Institute & State University
| 4 jaar |
Ryan Burch | M | - |
Virginia Polytechnic Institute & State University
| - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 99 | 99.00% |
Nederland | 1 | 1.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Charlie Petty
- Persoonlijk netwerk